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QSAR analysis of a set of benzoxazoles, benzimidazoles, oxazolo[4,5-b]pyridines and ben-
zothiazoles, showing growth inhibitory activity against Candida albicans, was performed us-
ing a multiple regression procedure. Topological indices (TIs) and principal component analysis
(PCA) on TIs were used in modeling antifungal activity. Selection of TIs relevant to develop-
ing QSAR models was made using the largest PC factor loading scores. Correlation coefficient
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Mycosis diseases are affections caused by body infestat
ion with pathogenic mycosis parasites of pathogenic po-
tential. Some of these fungi live in nature as saprophytes
(exogenetic saprophytes) or in the human body or ani-
mals (endogenetic saprophytes) and they accidentally be-
come parasites.
Affections produced by mycosis parasites are wide-
ly spread worldwide, with predominance in some areas.
Superficial mycosis affections are frequently encountered
in our country. Candidiasis, an infection caused by Can-
dida, a yeast-like fungus, is such an affection.
Candida species are ubiquitous fungi, existing as nor-
mal body flora. Candidiasis infection causes a variety of
diseases, ranging from superficial disorders such as diaper
rash to invasive, rapidly fatal infections in immunocom-
promized hosts. Candida albicans is commonly respon-
sible for candidiasis, but others, such as Candida tropicalis,
Candida parapsilosis, Candida guilliermondi, and Toru-
lopsis glabrata are also causative organisms.1
Candidiasis affects a wide variety of organ systems.
In immunocompetent persons, any warm, moist part of
the body exposed to the environment is susceptible to in-
fection. In immunocompromized patients, systemic disea-
ses such as myocarditis and hepatosplenic abscess occur
and antifungal therapy should be started immediately af-
ter necessary cultures have been obtained from all sus-
pected sites of infection.
Antifungals — Amphotericin B, fluconazole, ketoco-
nazole, and nystatin are the drugs most commonly used
to treat candidiases. Most fungi are completely resistant
to the action of antimicrobial drugs. Only a few substan-
ces have been discovered that exert an inhibitory effect
on the fungi pathogenic to man, and most of these are
relatively toxic.2
In this context, the synthesis of some novel derivatives
of benzoxazoles, benzimidazoles, oxazolo[4,5-b]pyridi-
nes and benzothiazoles over the last few years3–7 was
welcome.
DATA SET
Compounds 1–68, included in this QSAR analysis, have
shown antifungal activity at MIC (minimum inhibitory
concentration) values between 6.25–50 g/ml, against
Candida albicans, comparable to the activity of com-
monly used antifungals, such as Clotrimazole, Oxicona-
zole and Haloprogin.5
In this study, QSAR analysis of antifungal benzoxa-
zoles, benzimidazoles and oxazolo[4,5-b]pyridines 1–68
is presented. Table I lists the formulas and activity data,
log(1/C), for the above mentioned structures.
DATA ANALYSIS
QSAR analysis consists of the following steps: (i) struc-
ture optimization using the semiempirical method PM3;
(ii) calculation of molecular descriptors; (iii) classifica-
tion using the Good similarity index; (iv) principal com-
ponent analysis (PCA); (v) correlation analysis using
step-forward selection of descriptors; (vi) multiple re-
gression analysis by selected descriptors from PCA; (vii)
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TABLE I. The structure and in vitro antifungal activity of compounds
1–68 against C. albicans
X Y Z R R1 R2 log(1/C)
1 CH O – H H H 3.892
2 CH O – C(CH3)3 H H 4.001
3 CH O – NH2 H H 3.924
4 CH O – NHCH3 H H 3.952
5 CH O – C2H5 Cl H 4.013
6 CH O – NHCOCH3 Cl H 4.059
7 CH O – NHCH3 Cl H 4.015
8 CH O – Cl Cl H 4.024
9 CH O – NO2 Cl H 4.04
10 CH O – H NO2 H 4.282
11 CH O – CH3 NO2 H 4.308
12 CH O – C(CH3)3 NO2 H 4.375
13 CH O – NH2 NO2 H 4.31
14 CH O – Cl NO2 H 4.342
15 CH O – Br NO2 H 4.406
16 CH O – C2H5 NH2 H 3.979
17 CH O – F NH2 H 3.96
18 CH O – N(CH3)2 CH3 H 4.005
19 CH O – CH3 CH3 H 3.95
20 CH O – C2H5 CH3 H 3.977
21 CH O – OCH3 CH3 H 3.98
22 CH O – F CH3 H 3.958
23 CH O – NHCOCH3 CH3 H 4.027
24 CH O – NHCH3 CH3 H 3.979
25 CH O – N(CH3)2 CH3 H 4.004
26 N O – CH3 H H 4.225
27 N O – C2H5 H H 4.253
28 N O – OCH3 H H 4.257
29 N O – OC2H5 H H 4.283
30 N O – NH3 H H 4.227
31 N O – NO2 H H 4.285
32 CH O CH2 H H H 4.223
33 CH O CH2 OCH3 H H 4.282
34 CH O CH2 Cl H H 4.29
35 CH O CH2 NO2 H H 4.308
36 CH O CH2 H Cl H 4.29
37 CH O CH2 OCH3 Cl H 4.34
38 CH O CH2 Br Cl H 4.41
39 CH O CH2 NO2 Cl H 4.363
40 CH O CH2 H NO2 H 4.609
41 CH O CH2 OCH3 NO2 H 4.657
42 CH O CH2 Br NO2 H 4.725
43 CH O CH2 Cl NO2 H 4.664
44 CH O CH2 NO2 NO2 H 4.68
45 CH O CH2O H CH3 H 3.98
46 CH O CH2O H H NO2 3.732
47 CH O CH2O H CL NO2 3.785
48 CH O CH2O Cl CL NO2 3.831
49 CH O CH2S H NO2 H 4.359
50 CH O CH2S H CH3 H 4.009
51 N O CH2O H H H 4.26
52 N O CH2O Cl H H 4.319
53 CH NH CH2O Cl CH3 H 4.037
54 CH NH CH2S H NO2 H 4.358
55 CH NH CH2S H CH3 H 4.009
56 CH O CH2O H COOCH3 H 4.054
57 CH O CH2O Cl COOCH3 H 4.104
58 CH NH CH2O Cl COOCH3 H 4.102
59 CH NH CH2S H COOCH3 H 4.076
60 CH O C2H4 H NO2 H 4.331
61 N O C2H4 H H H 4.253
62 CH O – Br NH2 H 4.11
63 CH O CH2 Br H H 4.36
64 CH O CH2O Cl H H 4.016
65 CH NH CH2O H NO2 H 4.283
66 CH NH CH2O Cl H H 4.015
67 CH NH CH2S H Cl H 4.041










evaluation of the significance level of the model; (viii)
validation of the model, and (ix) interpretation of the re-
sults.
Our structures were optimized by using the semi
empirical PM3 Hamiltonian, available in HyperChem.
A large pool of descriptors, provided by the TOPO-
CLUJ software package,8 was calculated for every mole-
cule. The descriptors list includes: (i) topological descrip-
tors (Wiener,9 Randi},10 etc.); (ii) constitutional indicator
descriptors (e.g., absence or presence of certain functio-
nal groups in the molecular structure); (iii) quantum cal-
culated descriptors (HOMO energy – highest occupied
molecular orbital, and LUMO energy – lowest occupied
molecular orbital, dipole moment, total electronic energy);
(iv) force field parameters – F (field effect) for electro-
nic description and (v) steric descriptors (L and B4) for
substituents R and R1.11–14
Similarity expresses the relatedness of two molecu-
les, with a large number if their molecular descriptions
are closely related and with a number approaching zero
in case they are unrelated. The Good index is one of the
most used coefficients of similarity:13–16













where IAk refers to the k indices for compound A and IBk
to the k indices for compound B. It takes values in the










with wk being the weighting factor for descriptor k.
The initial data set (68 antifungal compounds) was
split into 3 subsets: two training subsets (n = 29 for sub-
set 1 and n = 30 for subset 2), clustering the ordered BA
values (for the regression calibration) and one external
(randomly selected, n = 9) validation subset (see the left
column of Table II). The quality of prediction depends on
correct classification of presumably »unknown« com-
pounds with respect to the training subsets.
The values in Table II are Good index frequencies,
calculated according to Eq. (2), for each compound in the
external validation subset with respect to each structure
in both training subsets. Boldface values indicate the maxi-
mal frequency and thus the subset to which each com-
pound of the validation subset belongs.
Principal components analysis, PCA, is a very power-
ful statistical technique useful for reducing the noise of
the data set and eliminating uncorrelated variables. Due
to the high complexity of interactions between the recep-
tor molecule and potential inhibitor molecules, it is often
difficult to model BA using simple linear regression mo-
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(a) The values are Good index frequencies, calculated according to Eq. (2).
(b) Boldface values indicate the maximal frequency.
Projection of the cases on the factor-plane (1 x 2)
Cases with sum of cosine square >= 0.00
Active



















Projection of the cases on the factor-plane (1 x 2)
Cases with sum of cosine square >= 0.00
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Quality of representation 100 %
No. of active cases 29
No. of components 33
Subset 2
Quality of representation 100 %
No. of active cases 30
No. of components 33
Figure 1. Principal component analysis, projection on factor coordinates.
dels. In this study, we used a large pool of descriptors
(864) to derive the QSAR model; PCA will help reduce
the data drastically (see Figure 1).17
Since eigenvalues are sorted in descending order, the
first PC will describe the greatest amount of data varian-
ce. The second PC will describe the greatest amount of
data variance in a direction orthogonal to the first PC.
The first two PCs account for more than 94 % (94.62 %
for subset 1 and 94.71 % for subset 2, respectively) of
data variance, indicating that data variance can be well
described in only two dimensions. 17
Loading plots can be used to evaluate the relevant
descriptors. A high loading value indicates that the PC is
aligned in a direction close to the original descriptor res-
ponse. Selection of descriptors, contributing highly to data
variance, can be accomplished by examining the loading
plots or tables. Additionally, the relation of descriptors
to each other (i.e., co-linearity) can be explored.
We selected 6 PCs in each training subsets, for a re-
presentation quality of 99 %, and, for each PC, 5 descrip-
tors with the greatest loadings as independent variables.
Thus, we greatly reduced the searching space (descrip-
tor’s pool) by one order of magnitude (from 864 to 22
for subset 1 and from 864 to 24 for subset 2). In the next
step, automated selection of descriptors was performed
by the forward stepwise procedure.
The derived QSAR multivariate models are present-
ed in Table III (b – regression coefficients of the vari-
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TABLE III. Statistics for derived QSAR models for antifungal compounds in Table I(a)
b Std. error t p-level
Subset 1
Intercept 1.845E+00 2.237E-01 8.2468 2.407E-07
WkOp[Detour U Adjacency] –6.402E-04 7.880E-05 –8.1252 2.953E-07
PDS[Sh[U]] 1.092E-03 2.092E-04 5.2182 6.959E-05
Distance 1.296E-01 1.011E-02 12.8173 3.649E-10
PDS4[Sh[Detour]] –1.941E-04 2.597E-05 –7.4746 9.087E-07
PDS4[LM[Charge]] –1.648E-02 2.389E-03 –6.8972 2.584E-06
PRD^2S[LM[Charge]] –2.582E-02 4.235E-03 –6.0984 1.182E-05
PDS2[LM[Charge]] 1.063E-01 7.039E-03 15.1085 2.761E-11
Subset 2
Intercept 4.171E+00 1.224E-01 34.0747 7.744E-22
PRD^2S[Sh[CjMax[Covalent radius]]] 3.553E-03 5.744E-04 6.1859 2.161E-06
PDS8[LM[Charge]] 2.822E-02 2.651E-03 10.6459 1.428E-10
PDS3[Sh[Detour]] –6.179E-04 8.158E–05 –7.5745 8.190E-08
PDS6[Sh[Detour]] 2.018E-04 9.255E-05 2.1802 3.928E-02
(a) b – regression coefficients of the variables, Std. error – standard deviation of a mean, t – test for independent samples, p-level – probability of error.
Dependent variable: log(1/ )C
Analysis sample
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R2 = 0.9635; s = 0.0132; F = 64.222;
p = 5.49E–11; n = 29
R2 = 0.9095; s = 0.1223; F = 60.129;
p = 3.71E–12; n = 30
Figure 2. Predicted vs. observed values for the training subsets 1 and 2 (s – square root of the mean square for error, F – the ratio of the
model mean square to the error mean square, p – probability of error).
ables; Std. error – standard deviation of a mean; p-level
– probability of error) and plots in Figure 2 (for subset 1
(R2 > 0.96) and for subset 2 (R2 > 0.90)). The square
root of the mean square for error (s), the ratio of the mo-
del mean square to the error mean square (F), and pro-
bability of error (p) were also recorded.
Both models were tested for statistical significance,
by a random exchange of BA column entries, within each
subset; a dramatic drop of the correlation coefficient prov-
ed that no chance correlation occurred in our models.
Validation of the models, on the external validation
dataset (Table IV, Figure 3), indicated a good prediction
ability (R2 > 0.97) of the observed BA. Thus, the derived
models can be used in prediction of BA for new com-
pounds, in homologous series.
Note that the published18 QSAR models, based on
certain physicochemical properties or structural indicator
variables, have good correlation coefficients but lower pre-
diction ability (R2 = 0.67).
CONCLUSION
In this paper, we have presented a QSAR model for a set
of antifungal compounds. Our attention was focused on
model development and validation. Statistical tools such
as PCA and stepwise regression analysis have been em-
ployed. Another important aspect taken into considera-
tion was the correct splitting of the data set into training
and validation subsets, which can considerably affect the
results. The derived models indicated good prediction abi-
lity, thus being useful in evaluation of BA for new or not
screened compounds, in homologous series. The obtained
high quality QSAR models can be used in large database
mining to find compounds with antifungal activity. Note
that during the lead discovery processes, in high through-
put screening of large databases, such QSAR models can
be employed for data clustering, thus avoiding screening
for antifungal activity of irrelevant structures. This could
represent an early step in guiding the synthetic chemistry
of a drug, notably of antifungal compounds.
We stress here that complementary studies on the toxi-
city of such compounds are needed in order to avoid po-
tent antifungal but toxic structures, or at least to balance
between the desired and undesired properties within a set
of biologically active designed compounds. More elaborate
modeling and drug design, aimed at gaining the specific
antifungal activity (not easily achievable in others, because
of the eukaryotic structure of Candida) are also required.
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R 2 = 0.9709
Figure 3. Graphical representation of data given in Table IV.
TABLE IV. Prediced and residual values in the validation set, n = 9
Compd. BAobs. BApred. Residual CV/%
a17 4.253 4.219 0.034 0.799
a27 4.282 4.265 0.017 0.397
a33 4.283 4.217 0.066 1.541
a35 4.308 4.312 –0.004 0.093
a47 3.785 3.804 –0.019 0.502
a53 3.96 3.949 0.011 0.278
a58 4.015 4.024 –0.009 0.224
a65 4.037 4.075 –0.038 0.941
a07 4.102 4.138 –0.036 0.878
SA@ETAK
QSAR-modeliranje protugljivi~noga djelovanja nekih heterocikli~kih spojeva
Oleg Ursu, Adina Costescu, Mircea V. Diudea i Bazil Parv
Metodom vi{estruke regresije u~injena je QSAR-analiza niza benzoksazola, benzimidazola, oksazolo-
[4,5-b]piridina i benzotiazola, ~ije je inhibitorno djelovanje na Candida albicans ispitivano. Topolo{ki indeksi
(TI) i analiza njihovih glavnih komponenata (PCA, Principal Component Analysis) uporabljeni su za mode-
liranje protugljivi~noga djelovanja. Izbor odgovaraju}ih topolo{kih indeksa za izradu QSAR-modela u~injen je
temeljem najvi{ih rezultata faktora glavnih komponenata. Korelacijski koeficijent 0,97 utvr|en u validacijsko-
me postupku ukazuje na visoku kakvo}u izra|enih QSAR-modela.
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